Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026
← All news
Markets

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

1 source ·1 article ·1h ago

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.

Covered by 1 outlet

Marketwatch 1

All coverage · 1 article

MarketWatch Top Stories ·1h ago

After capital-markets day flop, Novo strikes licensing deal that sends a Swedish company’s stock soaring

Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over $1 billion.